Skip to main content

Clinical Pipeline

Investor Relations

Shareholders Letter and amended Proxy

2025-07-04press-release

About

Vidac is a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class therapies for oncology and onco-dermatology indications.

Vidac Pharma Holding PLC

Dr. Max Herzberg

20-22 Wenlock Road

London N1 7GU

United Kingdom

Legal

Privacy Policy

© 2016 – 2026 Vidac